Patent
Peptidase resistenter peptid-ligand des thrombinrezeptors
Barry S. Coller,Glenn D. Prestwich +1 more
- 30 Jun 1994
About: The article was published on 30 Jun 1994.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
References
Thrombin receptor activating peptides: importance of the N-terminal serine and its ionization state as judged by pH dependence, nuclear magnetic resonance spectroscopy, and cleavage by aminopeptidase M
Barry S. Coller,Patrick E. Ward,Marco Ceruso,Lesley E. Scudder,Karen T. Springer,Jeffery L. Kutok,Glenn D. Prestwich +6 more
TL;DR: Induction of platelet aggregation by these two peptides showed an unusual pH dependence, being more potent at pH 7.2 than at pH 8.1; thrombin-induced aggregation showed a reverse pH dependence.
77
Substituting isoserine for serine in the thrombin receptor activation peptide SFLLRN confers resistance to aminopeptidase M-induced cleavage and inactivation.
Barry S. Coller,Karen T. Springer,Lesley E. Scudder,Jeffery L. Kutok,Marco Ceruso,Glenn D. Prestwich +5 more
TL;DR: The substituted (iso-S)FLLRN peptide should permit improved analysis of the effects of constant levels of peptide-induced thrombin receptor stimulation in the presence of plasma or serum, or when testing theeffects of the peptide on cells that contain surface-associated aminopeptidase M.
42